stockportfolio.pro
Stocks / TEVA vs WAT
TEVA vs WAT
Teva Pharmaceutical Industries Limited and Waters Corporation side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Teva Pharmaceutical Industries Limited (TEVA) | Waters Corporation (WAT) | |
|---|---|---|
| Market cap | $40.1B | $35.1B |
| Revenue (latest FY) | $17.26B | $3.17B |
| Net income (latest FY) | $1.41B | $642.63M |
| Revenue growth (5y CAGR) | 0.7% | 6.0% |
| Net margin | 8.2% | 20.3% |
| Return on equity | 17.8% | 25.1% |
| P/E ratio | 25.7 | 45.2 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 3 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open TEVA — free Open WAT — freeFrequently asked questions
Which is bigger, TEVA or WAT?
Teva Pharmaceutical Industries Limited is larger by market capitalization — $40.1B versus $35.1B.
Which grows faster, TEVA or WAT?
Over the last five fiscal years, Waters Corporation grew revenue faster — 6.0%/yr versus 0.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.